Symyx Technologies — Merger or Acquisition (April 2010)
15 slides from Symyx Technologies's merger presentation, Apr 5, 2010
Slide 1: Accelrys & Symyx Investor Presentation
Accelrys & Symyx Investor Presentation
Slide 2: Safe Harbor Information
Company Confidential Safe Harbor Information 2 Non-historical statements in this presentation are forward- looking statements under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks, uncertaint
Slide 3: Accelrys and Symyx to Merge
Company Confidential Accelrys and Symyx to Merge 3 Accelrys and Symyx Agree to Merge • Companies have entered into definitive merger agreement • Transaction expected to complete by end of June 2010 subject to shareholder approval Merger Outcome • Creates the leading enterprise scientific informatics
Slide 4: Combining Industry Leaders
Company Confidential Combining Industry Leaders 4 Founded: 2001 Public: ACCL (NASDAQ) FY 2009 Revenue: $80.9M Leading positions in: § Data Collection and Analysis § Data Access, Integration & Transformation § Scientific Modeling and Simulation § Workflow Automation and Optimization Employees: 370 He
Slide 5: Scientific R&D Challenges Balance Innovation, Automation, Collaboration
Company Confidential Scientific R&D Challenges Balance Innovation, Automation, Collaboration Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards. Eric David, Tony Tramontin, and
Slide 6: Combined Company Addresses Required Needs
Company Confidential Combined Company Addresses Required Needs 6 Unequaled capabilities in scientific software and services Ø Deep domain expertise in chemistry, biology and materials science Ø Ability to improve scientific R&D processes and their outcomes Ø Unique, open, enterprise scale informatic
Slide 7: Combined Company Solution
Company Confidential Combined Company Solution Decision Support and Analytics Workflow Automation Deep analysis of complex scientific information Optimize processes and capture best practices Derivation of models, improved scientific insights and understanding Process optimization, deployment of bes
Slide 8: Leading in Scientific R&D Workflows in Growing Markets
Company Confidential Leading in Scientific R&D Workflows in Growing Markets Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System 8 Create, Execute and Reuse Scien
Slide 9: Global Brand Customer Portfolio and Minimal Product Overlap
Company Confidential With Global Brand Customer Portfolio and Minimal Product Overlap Customer Synergies Complementary Product Lines 9 Accelrys + Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5
Slide 10: Vibrant & Growing Partner Ecosystem
Company Confidential Vibrant & Growing Partner Ecosystem Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System 10 Additional applications and solutions developed b
Slide 11: Terms of Deal
Company Confidential Terms of Deal Merger Agreement Tax-free, all stock merger of equals Closing Expected to close end of June 2010 Exchange Ratio 0.7802 Ownership Each company’s stockholders will own approximately 50% of combined company Market Capitalization Combined market cap of ~ $335M (pre-ann
Slide 12: Pro Forma Combined CY2009 Financial Metrics
Company Confidential Metric (1) Accelrys Symyx Pro Forma Combined (2) CY2009 Revenue $82.2 $88.6 $170.8 CY2009 EBIT $6.0 $11.0 $17.0 CY2009 EBITDA (5) $7.8 $14.0 $21.8 Net Cash (3) $72.0 $81.8 $153.8 Market Capitalization (4) $179.8 $155.1 $334.9 Pro Forma Combined CY 2009 Financial Metrics 12 (1) S
Slide 13: Accelrys & Symyx
Accelrys & Symyx
Slide 14: Forward Looking Statements
Company Confidential Forward Looking Statements 14 Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to a variety of matters, including but not limited to: the timing
Slide 15: Important Merger Information and Where to Find It
Company Confidential Important Merger Information and Additional Information and Where to Find It 15 This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed merger, Accelr
Symyx Technologies — Merger or Acquisition (April 2010) on 6ix